Table 2.
Characteristics according to HCC development (n = 278)
| HCC +ve | HCC –ve | ||
|---|---|---|---|
| n | 41 | 237 | |
| Age (years) | 62 ± 11 (44–82) | 56.0 ± 12 (18–84) | 0.003 |
| Male, n (%) | 30 (73.2) | 147 (62.0) | 0.171 |
| Aetiology, n (%) | 0.007 | ||
| Viral | 35 (85.4) | 151 (63.7) | |
| Non-viral | 6 (14.6) | 86 (36.3) | |
| Liver stiffness (kPa) | 40.3 ± 15.2 (20.6–75) | 33.6 ± 13.7 (18–75) | 0.005 |
| IQR/med | 0.22 ± 0.15 (0–0.64) | 0.22 ± 0.16 (0–1.1) | 0.998 |
| Success rate (%) | 81 ± 27 (0–100) | 91 ± 15 (10–100) | 0.127 |
| Probe (%) | |||
| S | 2 (4.9) | 3 (1.3) | |
| M | 34 (83.0) | 189 (79.7) | |
| XL | 5 (12.2) | 45 (19.0) |
Abbreviations: ALD, alcoholic liver disease; NAFLD, non-alcoholic fatty liver disease; HBV, hepatitis B virus; HCV, hepatitis C virus; IQR, interquartile range; S, small; M, medium; XL, extra-large.
Significant differences in bold.